Literature DB >> 27077732

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice.

Yoko A Ito1, Nicolas Belforte1, Jorge L Cueva Vargas1, Adriana Di Polo2.   

Abstract

The use of rodent models of glaucoma has been essential to understand the molecular mechanisms that underlie the pathophysiology of this multifactorial neurodegenerative disease. With the advent of numerous transgenic mouse lines, there is increasing interest in inducible murine models of ocular hypertension. Here, we present an occlusion model of glaucoma based on the injection of magnetic microbeads into the anterior chamber of the eye using a modified microneedle with a facetted bevel. The magnetic microbeads are attracted to the iridocorneal angle using a handheld magnet to block the drainage of aqueous humour from the anterior chamber. This disruption in aqueous dynamics results in a steady elevation of intraocular pressure, which subsequently leads to the loss of retinal ganglion cells, as observed in human glaucoma patients. The microbead occlusion model presented in this manuscript is simple compared to other inducible models of glaucoma and also highly effective and reproducible. Importantly, the modifications presented here minimize common issues that often arise in occlusion models. First, the use of a bevelled glass microneedle prevents backflow of microbeads and ensures that minimal damage occurs to the cornea during the injection, thus reducing injury-related effects. Second, the use of magnetic microbeads ensures the ability to attract most beads to the iridocorneal angle, effectively reducing the number of beads floating in the anterior chamber avoiding contact with other structures (e.g., iris, lens). Lastly, the use of a handheld magnet allows flexibility when handling the small mouse eye to efficiently direct the magnetic microbeads and ensure that there is little reflux of the microbeads from the eye when the microneedle is withdrawn. In summary, the microbead occlusion mouse model presented here is a powerful investigative tool to study neurodegenerative changes that occur during the onset and progression of glaucoma.

Entities:  

Mesh:

Year:  2016        PMID: 27077732      PMCID: PMC4841308          DOI: 10.3791/53731

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  19 in total

1.  Experimental glaucoma in the primate induced by latex microspheres.

Authors:  A J Weber; D Zelenak
Journal:  J Neurosci Methods       Date:  2001-10-15       Impact factor: 2.390

2.  A novel method for the induction of experimental glaucoma using magnetic microspheres.

Authors:  Paulina A Samsel; Lilian Kisiswa; Jonathan T Erichsen; Stephen D Cross; James E Morgan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-25       Impact factor: 4.799

3.  Longitudinal non-invasive proton NMR spectroscopy measurement of vitreous lactate in a rabbit model of ocular hypertension.

Authors:  Quintus C Ngumah; Steven D Buchthal; Ramon F Dacheux
Journal:  Exp Eye Res       Date:  2006-04-24       Impact factor: 3.467

4.  The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

Authors:  Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

5.  Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.

Authors:  J Haritz Urcola; María Hernández; Elena Vecino
Journal:  Exp Eye Res       Date:  2006-05-06       Impact factor: 3.467

6.  Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection.

Authors:  Frances E Cone; Scott E Gelman; Janice L Son; Mary E Pease; Harry A Quigley
Journal:  Exp Eye Res       Date:  2010-06-26       Impact factor: 3.467

Review 7.  Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma.

Authors:  John C Morrison; William O Cepurna Ying Guo; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2010-08-11       Impact factor: 3.467

8.  Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas.

Authors:  Francisco M Nadal-Nicolás; Manuel Jiménez-López; Paloma Sobrado-Calvo; Leticia Nieto-López; Isabel Cánovas-Martínez; Manuel Salinas-Navarro; Manuel Vidal-Sanz; Marta Agudo
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

9.  Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.

Authors:  M Almasieh; Y Zhou; M E Kelly; C Casanova; A Di Polo
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

10.  REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury.

Authors:  B Morquette; P Morquette; J Agostinone; E Feinstein; R A McKinney; A Kolta; A Di Polo
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

View more
  24 in total

1.  Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model.

Authors:  Emiel Geeraerts; Marie Claes; Eline Dekeyster; Manuel Salinas-Navarro; Lies De Groef; Chris Van den Haute; Isabelle Scheyltjens; Veerle Baekelandt; Lutgarde Arckens; Lieve Moons
Journal:  J Neurosci       Date:  2019-01-17       Impact factor: 6.167

2.  Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma.

Authors:  Milica A Margeta; Zhuoran Yin; Charlotte Madore; Kristen M Pitts; Sophia M Letcher; Jing Tang; Shuhong Jiang; Christian D Gauthier; Sebastian R Silveira; Caitlin M Schroeder; Eleonora M Lad; Alan D Proia; Rudolph E Tanzi; David M Holtzman; Susanne Krasemann; Dong Feng Chen; Oleg Butovsky
Journal:  Immunity       Date:  2022-08-16       Impact factor: 43.474

3.  Evidence for ceramide induced cytotoxicity in retinal ganglion cells.

Authors:  Jie Fan; Jiali Liu; Jian Liu; Chunhe Chen; Yiannis Koutalos; Craig E Crosson
Journal:  Exp Eye Res       Date:  2021-09-07       Impact factor: 3.770

4.  Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma.

Authors:  Qi N Cui; Albert R Bargoud; Ahmara G Ross; Ying Song; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2020-02-08       Impact factor: 3.467

5.  Induction of significant intraocular pressure diurnal fluctuation in rats using a modified technique of microbead occlusion.

Authors:  Lin Fu; Jimmy Shiu Ming Lai; Amy Cheuk Yin Lo; Kendrick Co Shih
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

6.  Optic Nerve Crush in Mice to Study Retinal Ganglion Cell Survival and Regeneration.

Authors:  Evan G Cameron; Xin Xia; Joana Galvao; Masoumeh Ashouri; Michael S Kapiloff; Jeffrey L Goldberg
Journal:  Bio Protoc       Date:  2020-03-20

7.  Preservation of vision after CaMKII-mediated protection of retinal ganglion cells.

Authors:  Xinzheng Guo; Jing Zhou; Christopher Starr; Ethan J Mohns; Yidong Li; Earnest P Chen; Yonejung Yoon; Christopher P Kellner; Kohichi Tanaka; Hongbing Wang; Wei Liu; Louis R Pasquale; Jonathan B Demb; Michael C Crair; Bo Chen
Journal:  Cell       Date:  2021-07-22       Impact factor: 66.850

8.  Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.

Authors:  Marius Chiasseu; Luis Alarcon-Martinez; Nicolas Belforte; Heberto Quintero; Florence Dotigny; Laurie Destroismaisons; Christine Vande Velde; Fany Panayi; Caroline Louis; Adriana Di Polo
Journal:  Mol Neurodegener       Date:  2017-08-03       Impact factor: 14.195

9.  A Fair Assessment of Evaluation Tools for the Murine Microbead Occlusion Model of Glaucoma.

Authors:  Marie Claes; Joana R F Santos; Luca Masin; Lien Cools; Benjamin M Davis; Lutgarde Arckens; Karl Farrow; Lies De Groef; Lieve Moons
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

10.  AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma.

Authors:  Nicolas Belforte; Jessica Agostinone; Luis Alarcon-Martinez; Deborah Villafranca-Baughman; Florence Dotigny; Jorge L Cueva Vargas; Adriana Di Polo
Journal:  Mol Neurodegener       Date:  2021-06-29       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.